Patients of an online obesity clinic achieved the same weight loss as those in clinical trials of semaglutide – but with much lower doses of the drug
New research being presented at this year’s European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials – but with less than half the medication. The study is to be published in the journal The Lancet Digital Health.
Patients who followed the programme had an average weight loss of 16.7% (16.8kg/2st 9lb) after 64 weeks, which is on par with that seen in randomised controlled trials of the same drug, semaglutide, a glucagon-like peptide-1 ...